Johnson & Johnson (NYSE:JNJ) currently has a daily average trading volume of 7.31M but it saw 9367980 shares traded in last market. With a market cap of 348.86B USD, the company’s current market price of $144.77 came rising about 0.22 while comparing to the previous closing price of $144.45. In past 52 weeks, the stock remained buoying in the range of price level as high as $175.97 and as low as $143.39.
Taking a look at 20-day trading activity of Johnson & Johnson (JNJ) gives us an average price of $152.79, while its current price level is -17.73% below from 52-week high level whereas it is 0.96% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $156.56 while that of 200 days or SMA-200 reads an average of $158.64. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.54% during that period while stretching the period over a month that decreases to 1.25%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 21.03 which implies that the stock is in oversold territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which downgraded the stock as “Equal Weight” in its note to investors issued on December 13, 2023, recommending a price target of between $170 and $163 for it. UBS upgraded its recommendation for the stock as a “Buy” from “Neutral” on December 01, 2023 while assigning a price target range of $167-$180. RBC Capital Mkts issued its recommendations for the stock as it initiated the price target for the stock is $178.
Over the week, JNJ’s stock price is moving -3.62% down while it is -7.65% when we observe its performance for the past one month. Year-to-date it is -7.64% down and over the past year, the stock is showing a downside performance of -12.62%.
Currently, Johnson & Johnson’s total number of outstanding shares is 2.41B. Company’s return on investment (ROI) stands at 20.46% and return on equity (ROE) at 18.57%. It has a price to earnings ratio (P/E ratio) of 18.55 while having a 13.18 of forward P/E ratio. Stock’s beta reads 0.55. Stock has a price to book (P/B) ratio of 5.07 while price to sale or P/S ratio amounts to 3.89. Its return on asset (ROA) is 7.62% on average.
